Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Northwestern University
• Treatments: Hyaluronic Acid

Criteria

Inclusion Criteria:

• Age 18 and over

• The subjects are in good health

• The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator

Exclusion Criteria:

• Under 18 years of age

• Pregnancy or Lactation

• Subjects who are unable to understand the protocol or to give informed consent

• Subjects with mental illness

• Recent Accutane use in the past 6 months

• Subjects prone to hypertrophic and keloidal scarring

• Subjects with tattoos and/or scars on upper medial arms (the treatment area)

• Subjects with known hypersensitivity to hyaluronic acid